Riskpilot← Back to searchSign inGet full accessSOLEID AS
ASActiveOrg 912848388Sinsenveien 47D, 0585 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 20131 employees
Revenue 2024
NOK 158K
-67% vs 2023
EBITDA margin
-320.4%
-32% vs 2023
Equity ratio
94.6%
Financial strength
Net profit 2024
NOK 14K
+104% vs 2023
| Revenue | NOK 158K | -67% |
| EBITDA | NOK -506K | -32% |
| Net profit | NOK 14K | +104% |
| Total assets | NOK 1,7M | -7% |
| Equity | NOK 1,6M | -5% |
| Employees | 1 | — |
Legal name
SOLEID AS
Org number
912848388
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
7. desember 2013
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Konsulentvirksomhet relatert til retail, e-handel og medisinsk industri samt å eie aksjer, andre investeringer og virksomhet som hører til det.
Address
Sinsenveien 47D, 0585 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 1 337 | 636 | 300 | 481 | 158 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −815 | −914 | −160 | −702 | −610 |
| EBITDA | −8 | −9 | −9 | −8 | −7 | −16 | 477 | −341 | 83 | −383 | −506 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −8 | −9 | −9 | −8 | −7 | −16 | 477 | −341 | 83 | −383 | −506 |
| Net financials | 0 | 0 | 0 | 31 | 88 | 1 250 | 240 | 206 | 200 | −50 | 419 |
| Profit before tax | −8 | −9 | −9 | 23 | 81 | 1 234 | 717 | −136 | 283 | −434 | −87 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | 93 | −74 | 20 | −83 | −101 |
| Net profit | −8 | −9 | −9 | 23 | 81 | 1 234 | 624 | −62 | 263 | −350 | 14 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 258 | 258 | 254 | 285 | 366 | 1 600 | 2 486 | 2 263 | 2 156 | 1 786 | 1 655 |
| Equity | 17 | 7 | −2 | 21 | 101 | 1 336 | 1 959 | 1 898 | 2 061 | 1 650 | 1 564 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 242 | 251 | 256 | 264 | 264 | 265 | 527 | 366 | 96 | 136 | 90 |
| Total debt | 242 | 251 | 256 | 264 | 264 | 265 | 527 | 366 | 96 | 136 | 90 |
EBITDA margin
-320.4%
This company
15.8%
Market median
-2128% vs market
20142024
Equity ratio
94.6%
This company
38.2%
Market median
+148% vs market
20142024
Return on equity
0.9%
This company
18.4%
Market median
-95% vs market
20142024
Net profit margin
8.9%
This company
8.1%
Market median
+10% vs market
20142024
Asset turnover
0.10×
This company
1.12×
Market median
-91% vs market
20142024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20142024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2013-12-01 – 2014-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2013 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SOLEID AS 
DKVISION ASBoard members of SOLEID AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Geir Arne Eide | Chairman | 0 companies |